- Home
- ATPC vs ALZN Comparison
ATPC vs ALZN Comparison
Compare ATPC & ALZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATPC
- ALZN
- Stock Information
- Founded
- ATPC 2016
- ALZN 2016
- Country
- ATPC Malaysia
- ALZN United States
- Employees
- ATPC N/A
- ALZN N/A
- Industry
- ATPC Medical/Nursing Services
- ALZN Medicinal Chemicals and Botanical Products
- Sector
- ATPC Health Care
- ALZN Health Care
- Exchange
- ATPC Nasdaq
- ALZN Nasdaq
- Market Cap
- ATPC 6.1M
- ALZN 7.0M
- IPO Year
- ATPC N/A
- ALZN 2021
- Fundamental
- Price
- ATPC $1.14
- ALZN $1.20
- Analyst Decision
- ATPC
- ALZN Strong Buy
- Analyst Count
- ATPC 0
- ALZN 1
- Target Price
- ATPC N/A
- ALZN $32.00
- AVG Volume (30 Days)
- ATPC 253.6K
- ALZN 169.8K
- Earning Date
- ATPC 02-15-2025
- ALZN 12-31-2024
- Dividend Yield
- ATPC N/A
- ALZN N/A
- EPS Growth
- ATPC N/A
- ALZN N/A
- EPS
- ATPC N/A
- ALZN N/A
- Revenue
- ATPC $1,354,042.00
- ALZN N/A
- Revenue This Year
- ATPC N/A
- ALZN N/A
- Revenue Next Year
- ATPC N/A
- ALZN N/A
- P/E Ratio
- ATPC N/A
- ALZN N/A
- Revenue Growth
- ATPC N/A
- ALZN N/A
- 52 Week Low
- ATPC $1.10
- ALZN $1.06
- 52 Week High
- ATPC $19.60
- ALZN $15.06
- Technical
- Relative Strength Index (RSI)
- ATPC 37.81
- ALZN 41.30
- Support Level
- ATPC $1.10
- ALZN $1.11
- Resistance Level
- ATPC $1.56
- ALZN $1.23
- Average True Range (ATR)
- ATPC 0.16
- ALZN 0.09
- MACD
- ATPC -0.01
- ALZN 0.01
- Stochastic Oscillator
- ATPC 12.00
- ALZN 39.29
About ATPC Agape ATP Corporation
Agape ATP Corp through its subsidiaries is engaged in providing health and wellness products and health solution advisory services. The principal activities of the company are to supply high-quality health and wellness products, including a supplement to assist in cell metabolism, detoxification, blood circulation, anti-aging and products designed to improve the overall health system in a body. Its product portfolio includes ATP1s Survivor Select, ATP2 Energized Mineral Concentrate, ATP3 Ionized Cal-Mag, ATP4 Omega Blend, AGN-Vege Fruit Fiber and Others.
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.